Literature DB >> 31462513

Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.

Hideru Obinata1, Andrew Kuo2, Yukata Wada3, Steven Swendeman2, Catherine H Liu4, Victoria A Blaho4, Rieko Nagumo3, Kenichi Satoh5, Takashi Izumi3, Timothy Hla6.   

Abstract

HDL-bound ApoM and albumin are protein chaperones for the circulating bioactive lipid, sphingosine 1-phosphate (S1P); in this role, they support essential extracellular S1P signaling functions in the vascular and immune systems. We previously showed that ApoM- and albumin-bound S1P exhibit differences in receptor activation and biological functions. Whether the physiological functions of S1P require chaperones is not clear. We examined ApoM-deficient, albumin-deficient, and double-KO (DKO) mice for circulatory S1P and its biological functions. In albumin-deficient mice, ApoM was upregulated, thus enabling S1P functions in embryonic development and postnatal adult life. The Apom:Alb DKO mice reproduced, were viable, and exhibited largely normal vascular and immune functions, which suggested sufficient extracellular S1P signaling. However, Apom:Alb DKO mice had reduced levels (∼25%) of plasma S1P, suggesting that novel S1P chaperones exist to mediate S1P functions. In this study, we report the identification of ApoA4 as a novel S1P binding protein. Recombinant ApoA4 bound to S1P, activated multiple S1P receptors, and promoted vascular endothelial barrier function, all reflective of its function as a S1P chaperone in the absence of ApoM and albumin. We suggest that multiple S1P chaperones evolved to support complex and essential extracellular signaling functions of this lysolipid mediator in a redundant manner.
Copyright © 2019 Obinata et al.

Entities:  

Keywords:  apolipoprotein A4; apolipoprotein M; apolipoproteins; high density lipoprotein; lipid transport; lysophospholipid; sphingosine 1-phosphate receptors

Mesh:

Substances:

Year:  2019        PMID: 31462513      PMCID: PMC6824498          DOI: 10.1194/jlr.RA119000277

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  45 in total

1.  The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine.

Authors:  O Stein; Y Stein; M Lefevre; P S Roheim
Journal:  Biochim Biophys Acta       Date:  1986-08-14

2.  The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors.

Authors:  Atsuo Kawahara; Tsuyoshi Nishi; Yu Hisano; Hajime Fukui; Akihito Yamaguchi; Naoki Mochizuki
Journal:  Science       Date:  2008-12-11       Impact factor: 47.728

3.  Apolipoprotein A-IV inhibits experimental colitis.

Authors:  Thorsten Vowinkel; Mikiji Mori; Christian F Krieglstein; Janice Russell; Fumito Saijo; Sulaiman Bharwani; Richard H Turnage; W Sean Davidson; Patrick Tso; D Neil Granger; Theodore J Kalogeris
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

4.  Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice.

Authors:  Eric Camerer; Jean B Regard; Ivo Cornelissen; Yoga Srinivasan; Daniel N Duong; Daniel Palmer; Trung H Pham; Jinny S Wong; Rajita Pappu; Shaun R Coughlin
Journal:  J Clin Invest       Date:  2009-07       Impact factor: 14.808

5.  Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation.

Authors:  X Qin; D K Swertfeger; S Zheng; D Y Hui; P Tso
Journal:  Am J Physiol       Date:  1998-05

6.  Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate.

Authors:  Rajita Pappu; Susan R Schwab; Ivo Cornelissen; João P Pereira; Jean B Regard; Ying Xu; Eric Camerer; Yao-Wu Zheng; Yong Huang; Jason G Cyster; Shaun R Coughlin
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

7.  HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.

Authors:  Sylvain Galvani; Marie Sanson; Victoria A Blaho; Steven L Swendeman; Hideru Obinata; Heather Conger; Björn Dahlbäck; Mari Kono; Richard L Proia; Jonathan D Smith; Timothy Hla
Journal:  Sci Signal       Date:  2015-08-11       Impact factor: 8.192

8.  Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family.

Authors:  H S Lichenstein; D E Lyons; M M Wurfel; D A Johnson; M D McGinley; J C Leidli; D B Trollinger; J P Mayer; S D Wright; M M Zukowski
Journal:  J Biol Chem       Date:  1994-07-08       Impact factor: 5.157

9.  Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes.

Authors:  S K Karathanasis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Apolipoprotein A-IV binds αIIbβ3 integrin and inhibits thrombosis.

Authors:  Xiaohong Ruby Xu; Yiming Wang; Reheman Adili; Lining Ju; Christopher M Spring; Joseph Wuxun Jin; Hong Yang; Miguel A D Neves; Pingguo Chen; Yan Yang; Xi Lei; Yunfeng Chen; Reid C Gallant; Miao Xu; Hailong Zhang; Jina Song; Peifeng Ke; Dan Zhang; Naadiya Carrim; Si-Yang Yu; Guangheng Zhu; Yi-Min She; Terry Cyr; Wenbin Fu; Guoqing Liu; Philip W Connelly; Margaret L Rand; Khosrow Adeli; John Freedman; Jeffrey E Lee; Patrick Tso; Patrizia Marchese; W Sean Davidson; Shaun P Jackson; Cheng Zhu; Zaverio M Ruggeri; Heyu Ni
Journal:  Nat Commun       Date:  2018-09-06       Impact factor: 14.919

View more
  14 in total

Review 1.  The Role of Phospholipid Transfer Protein in the Development of Atherosclerosis.

Authors:  Xian-Cheng Jiang; Yang Yu
Journal:  Curr Atheroscler Rep       Date:  2021-01-26       Impact factor: 5.113

2.  Sphingosine 1-Phosphate Metabolism and Signaling.

Authors:  Yan Hu; Kezhi Dai
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  PLTP deficiency-mediated atherosclerosis regression could be related to sphinogosine-1-phosphate reduction.

Authors:  Jiao Zheng; Ke Zhang; Zhiqiang Li; Tilla S Worgall; Xian-Cheng Jiang
Journal:  Atherosclerosis       Date:  2022-07-15       Impact factor: 6.847

4.  DOCK4 Regulation of Rho GTPases Mediates Pulmonary Vascular Barrier Function.

Authors:  Pascal Yazbeck; Xavier Cullere; Paul Bennett; Vijay Yajnik; Huan Wang; Kenji Kawada; Vanessa M Davis; Asit Parikh; Andrew Kuo; Vijayashree Mysore; Timothy Hla; David S Milstone; Tanya N Mayadas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-04-28       Impact factor: 10.514

Review 5.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Aging Suppresses Sphingosine-1-Phosphate Chaperone ApoM in Circulation Resulting in Maladaptive Organ Repair.

Authors:  Bi-Sen Ding; Dawei Yang; Steve L Swendeman; Christina Christoffersen; Lars B Nielsen; Scott L Friedman; Charles A Powell; Timothy Hla; Zhongwei Cao
Journal:  Dev Cell       Date:  2020-06-15       Impact factor: 12.270

Review 7.  Lysolipids in Vascular Development, Biology, and Disease.

Authors:  Eric Engelbrecht; Calum A MacRae; Timothy Hla
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-17       Impact factor: 8.311

Review 8.  The Endothelium Is Both a Target and a Barrier of HDL's Protective Functions.

Authors:  Jérôme Robert; Elena Osto; Arnold von Eckardstein
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

Review 9.  Apolipoprotein M-A Marker or an Active Player in Type II Diabetes?

Authors:  Christina Christoffersen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555

10.  Endothelial-Specific Loss of Sphingosine-1-Phosphate Receptor 1 Increases Vascular Permeability and Exacerbates Bleomycin-induced Pulmonary Fibrosis.

Authors:  Rachel S Knipe; Jillian J Spinney; Elizabeth A Abe; Clemens K Probst; Alicia Franklin; Amanda Logue; Francesca Giacona; Matt Drummond; Jason Griffith; Patricia L Brazee; Lida P Hariri; Sydney B Montesi; Katherine E Black; Timothy Hla; Andrew Kuo; Andreane Cartier; Eric Engelbrecht; Christina Christoffersen; Barry S Shea; Andrew M Tager; Benjamin D Medoff
Journal:  Am J Respir Cell Mol Biol       Date:  2022-01       Impact factor: 7.748

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.